H51.23 Internuclear ophthalmoplegia, bilateral

Name of the Condition

• Internuclear ophthalmoplegia, bilateral

Summary

Internuclear ophthalmoplegia (INO) is a neurological condition characterized by impaired horizontal eye movement, typically affecting adduction (inward movement) of both eyes and nystagmus (involuntary eye movement) of either eye when looking toward the affected side. This disorder disrupts binocular coordination and may result from damage to the medial longitudinal fasciculus (MLF), a brainstem pathway that coordinates eye movements. Symptoms often include double vision and difficulty tracking objects, particularly in horizontal gaze.

Causes

INO commonly arises from lesions or damage to the medial longitudinal fasciculus, which can occur due to multiple sclerosis, stroke, or other neurological conditions affecting the brainstem. Vascular events, such as ischemic or hemorrhagic strokes, are frequent causes, especially in older adults. Inflammatory processes, tumors, or trauma to the brainstem may also disrupt the MLF, leading to impaired eye movement coordination. In some cases, the condition may be associated with systemic diseases or degenerative disorders affecting the central nervous system.

Risk Factors

• Multiple sclerosis or other demyelinating disorders
• Stroke or cerebrovascular disease
• Brainstem lesions or tumors
• Neurological trauma or injury
• Systemic conditions affecting the central nervous system

Symptoms

• Impaired horizontal eye movement, particularly difficulty moving both eyes inward
• Nystagmus (involuntary eye movement) when looking toward the affected side
• Double vision (diplopia)
• Difficulty tracking objects in horizontal gaze
• Possible head turning to compensate for eye movement limitations

Diagnosis

Diagnosis involves a comprehensive eye examination, including assessment of eye movements and coordination. Neurological evaluation may include imaging studies such as MRI or CT scans to identify brainstem lesions or damage to the medial longitudinal fasciculus. Additional tests, such as visual field testing or electrophysiological studies, may be performed to confirm the diagnosis and rule out other conditions.

Treatment Options

Treatment focuses on addressing the underlying cause, such as managing multiple sclerosis or stroke. Symptomatic relief may include prism glasses to reduce double vision or eye muscle exercises. In some cases, medications or surgical interventions may be considered, depending on the specific etiology and severity of the condition.

Prognosis and Follow-Up

Prognosis varies based on the underlying cause. Recovery may be possible with treatment of the primary condition, such as in cases of reversible brainstem damage. Regular follow-up with a neurologist or ophthalmologist is recommended to monitor eye function and address any persistent symptoms or complications.

Complications

• Persistent double vision
• Difficulty with depth perception
• Impaired balance or coordination due to visual disturbances
• Potential progression of underlying neurological conditions

Lifestyle & Prevention

• Manage underlying conditions (e.g., multiple sclerosis, hypertension) to reduce risk of brainstem damage
• Avoid activities that increase stroke risk (e.g., smoking, excessive alcohol)
• Use protective measures to prevent head or brain trauma
• Follow recommended eye care practices to maintain overall visual health

When to Seek Professional Help

Seek immediate medical attention if you experience sudden onset of double vision, difficulty moving your eyes, or other neurological symptoms, as these may indicate a serious underlying condition requiring urgent evaluation.

Tips for Medical Coders

Document the bilateral nature of the internuclear ophthalmoplegia, including clinical findings and any associated neurological symptoms. Ensure the code H51.23 is used when the condition affects both eyes, and verify that supporting documentation aligns with the diagnosis to support accurate coding and billing.